Through screening of 241 different human tumors with the help of a profiling array and quantitative PCR, it is revealed that FGFRL1 aberrant expression might contribute to the development and progression of ovarian cancer (OC) [97]. The gene discussed is FGFRL1; the disease is ovarian carcinoma.